Claudia R. Nicolay
Bad Homburg Vor Der Hoehe, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Effects of Tirzepatide Versus Basal Insulins in People With Type 2 Diabetes and Different Baseline Glycemic Patterns: Post Hoc Analyses of the SURPASS-3 and SURPASS-4 Trials.
Journal: Diabetes care
Published: December 11, 2023
Relationship between body weight change and glycaemic control with tirzepatide treatment in people with type 2 diabetes: A post hoc assessment of the SURPASS clinical trial programme.
Journal: Diabetes, obesity & metabolism
Published: February 17, 2023
Dulaglutide and Kidney Function-Related Outcomes in Type 2 Diabetes: A REWIND Post Hoc Analysis.
Journal: Diabetes care
Published: February 08, 2023
Weight-dependent and weight-independent effects of dulaglutide on blood pressure in patients with type 2 diabetes.
Journal: Cardiovascular diabetology
Published: December 19, 2022
General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trial.
Journal: Cardiovascular diabetology
Published: November 28, 2022
Effect of expanded dulaglutide weekly doses (3.0 mg and 4.5 mg) on cardiovascular disease risk factors in participants with type 2 diabetes at increased cardiovascular disease risk: a post hoc analysis of the AWARD-11 study.
Journal: Diabetes, obesity & metabolism
Published: February 15, 2022
Efficacy and safety outcomes of dulaglutide by baseline HbA1c: A post hoc analysis of the REWIND trial.
Journal: Diabetes, obesity & metabolism
Published: February 09, 2022
New Rheumatoid Arthritis Treatments for 'Old' Patients: Results of a Systematic Review.
Journal: Advances in therapy
Published: May 22, 2020
A modeling framework for the economic evaluation of baricitinib in moderate-to-severe rheumatoid arthritis.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: March 28, 2020
A Network Meta-Analysis to Compare Effectiveness of Baricitinib and Other Treatments in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate.
Journal: Journal of health economics and outcomes research
Published: November 29, 2019
Last Updated: 09/26/2026